Vietnamese officials crack down on substandard drugs

As if taking a cue from the American Enterprise Institute report on substandard drugs, the Vietnam Drug Administration yesterday suspended some medications from circulation for failing to meet quality standards. Health authorities ordered importer Vemedimex to suspend sales of Cefiline tablets; importer Hiep Thuan Thanh was ordered to withdraw nutmorin H5000-anbicyn powder. Story

Suggested Articles

AbbVie will soon own Allergan’s prized Botox franchise, and along with its roughly $4 billion in sales, it will get a new $176 million plant.

Merck KGaA has big plans for a site in Switzerland where it intends to knit together biologics development and manufacturing. 

The FDA has found some issues with Biocon’s small molecule plant in Bengaluru, India.